These DEGs were not only enriched in biochemical processes related to the regulation of lymphocyte activation and cytokine receptor interaction pathways but also GSEA showed that C3 was likely to be involved in cancer-related pathways explaining the worse prognosis of C3 (Figures 3F, G). This evidence concerns the gene C3 and cancer.